“Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma”. Journal of Carcinogenesis 24, no. 8s (October 8, 2025): 553–562. Accessed December 26, 2025. https://carcinogenesis.com/index.php/JOC/article/view/1319.